---
title: "Trientine - Wilson's disease"
sidebar: mydoc_sidebar
permalink: db06824-mesh-d006527-1.html
toc: false 
---


Path ID: `DB06824_MESH_D006527_1`
{% include image.html url="images/db06824-mesh-d006527-1.png" file="db06824-mesh-d006527-1.png" alt="db06824-mesh-d006527-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D014266 | Trientine | Drug |
| MESH:D003300 | Copper | ChemicalSubstance |
| GO:0055070 | Copper ion homeostasis | BiologicalProcess |
| MESH:D006527 | Wilson's disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Trientine | MOLECULARLY INTERACTS WITH | Copper |
| Copper | POSITIVELY REGULATES | Copper Ion Homeostasis |
| Copper Ion Homeostasis | MANIFESTATION OF | Wilson'S Disease |
|---------|-----------|---------|

Comment: Trientine is the salt form of Triethylenetetramine (DB06824)

Reference: 
  - [https://go.drugbank.com/drugs/DB06824#mechanismofaction](https://go.drugbank.com/drugs/DB06824#mechanismofaction)
  - DOI:10.1158/1535-7163.MCT-10-0523
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry](https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry)
